Live Breaking News & Updates on Nancy Yovetich

Stay updated with breaking news from Nancy yovetich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rho's Approach To Overcoming Enrollment Challenges In A CNS Trial


By Nancy Yovetich, Ph.D., Principal Research Scientist
A mid-sized biotech company running a randomized, doubleblind, placebo controlled (1:1) Phase 3 CNS pain study, with a single treatment administration, had achieved ex-US approval yet faced significant enrollment challenges when a modified version of the study was implemented in the US. With a goal of 300 participants, the rate of enrollment sat at a mere 0.5 subjects a month. The best laid plans weren’t cutting it.
The Problem: Enrollment Challenges
Initial efforts to strategically adjust the enrollment criterion were disappointingly ineffective. Patient enrollment rates were lagging far behind goals, threatening to delay program start-up and obstruct research advancement. They turned to our experts for critical, creative thinking and innovative solutions. ....

Nancy Yovetich , Principal Research Scientist , Principal Research , ப்ரிந்ஸிபல் ஆராய்ச்சி விஞ்ஞானி , ப்ரிந்ஸிபல் ஆராய்ச்சி ,